Zoledronate in Preventing Bone Loss Caused By Long-Term Androgen Deprivation Therapy in Patients With Stage III or Stage IV Prostate Cancer

This study is ongoing, but not recruiting participants.

Study NCT00058188 Information provided by National Cancer Institute (NCI)

First Received: April 7, 2003 Last Updated: May 9, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)